Bnp Paribas Asset Management Holding S.A. Teva Pharmaceutical Industries LTD Transaction History

Bnp Paribas Asset Management Holding S.A.

$41 Billion
Q2 2025

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 59,926 shares of TEVA stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,926

Previous 25,472 135.26%

Holding current value

$1.18 Million

Previous $391,000 156.78%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	BUY	$12.82 - $18.15 $441,700 - $625,340	34,454 Added 135.26%	59,926 $1 Million
Q1 2025 May 13, 2025	BUY	$14.67 - $22.01 $373,674 - $560,638	25,472 New	25,472 $391,000
Q2 2021 Aug 05, 2021	SELL	$9.9 - $11.56 $134,362 - $156,892	-13,572 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$10.34 - $12.81 $41,266 - $51,124	-3,991 Reduced 22.72%	13,572 $157,000
Q4 2020 Feb 12, 2021	SELL	$8.61 - $11.04 $100,685 - $129,101	-11,694 Reduced 39.97%	17,563 $169,000
Q3 2020 Nov 09, 2020	BUY	$8.57 - $12.69 $146,821 - $217,405	17,132 Added 141.29%	29,257 $264,000
Q2 2020 Aug 04, 2020	BUY	$8.12 - $13.12 $98,454 - $159,080	12,125 New	12,125 $150,000
Q2 2019 Aug 02, 2019	SELL	$8.12 - $15.72 $228,724 - $442,800	-28,168 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$15.58 - $20.01 $84,194 - $108,134	-5,404 Reduced 16.1%	28,168 $442,000
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $236,649 - $386,684	-16,220 Reduced 32.58%	33,572 $527,000
Q2 2018 Aug 01, 2018	SELL	$16.77 - $24.71 $1.27 Million - $1.87 Million	-75,520 Reduced 60.27%	49,792 $1.22 Million
Q1 2018 May 07, 2018	BUY	$16.68 - $22.07 $2.09 Million - $2.77 Million	125,312 New	125,312 $2.14 Million

Others Institutions Holding TEVA

# of Institutions

663

Shares Held

664M

Call Options Held

30.1M

Put Options Held

16.4M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $21.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Teva Pharmaceutical Industries LTD Transaction History